Thus, the underlying mechanism of periostin in the regulation of the metabolic pathway needs further exploration to clarify its clinical points against dyslipidemia, diabetes, and obesity. This evidence concerns the gene POSTN and obesity due to melanocortin 4 receptor deficiency.